Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days

NCT00791388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: PG-760564
DRUG: PG-760564
DRUG: PG-760564
DRUG: PG-760564

Sponsor

Procter and Gamble